|
2024-04-03 |
2024-04-01 |
PS
Planned sale
|
Morabito Christopher
Chief Medical Officer
Officer
|
10,000
-100.0%
13.59
USD 135,939
|
10,000
-100.0%
|
13.59
|
USD 135,939
|
|
|
2024-02-05 |
2024-02-01 |
B
Purchase
|
PERCEPTIVE ADVISORS LLC
Non-Executive Director
|
2,481,350
+103.7%
12.09
USD 29,999,522
|
2,481,350
+103.7%
|
12.09
|
USD 29,999,522
|
|
|
2024-01-30 |
2024-01-29 |
PS
Planned sale
|
Morabito Christopher
Chief Medical Officer
Officer
|
9,200
-100.0%
11.15
USD 102,552
|
9,200
-100.0%
|
11.15
|
USD 102,552
|
|
|
2024-01-30 |
2024-01-26 |
PS
Planned sale
|
Morabito Christopher
Chief Medical Officer
Officer
|
800
-100.0%
11.02
USD 8,812
|
800
-100.0%
|
11.02
|
USD 8,812
|
|
|
2023-12-22 |
2023-12-21 |
B
Purchase
|
PERCEPTIVE ADVISORS LLC
Non-Executive Director
|
740,000
+44.8%
6.20
USD 4,588,000
|
740,000
+44.8%
|
6.20
|
USD 4,588,000
|
|
|
2023-10-18 |
2023-10-16 |
B
Purchase
|
PERCEPTIVE ADVISORS LLC
Non-Executive Director
|
460,546
+40.0%
6.51
USD 2,999,997
|
460,546
+40.0%
|
6.51
|
USD 2,999,997
|
|
|
2023-10-18 |
2023-10-16 |
B
Purchase
|
PERCEPTIVE ADVISORS LLC
Non-Executive Director
|
614,062
+59.1%
6.51
USD 4,000,000
|
614,062
+59.1%
|
6.51
|
USD 4,000,000
|
|
|
2022-12-21 |
2022-12-19 |
B
Purchase
|
PERCEPTIVE ADVISORS LLC
Non-Executive Director
|
908,265
+698.4%
11.01
USD 9,999,998
|
908,265
+698.4%
|
11.01
|
USD 9,999,998
|
|
|
2021-11-23 |
2021-11-19 |
B
Purchase
|
Komjathy Andrew
Chief Commercial Officer
Officer
|
100
+inf%
6.70
USD 670
|
100
+inf%
|
6.70
|
USD 670
|
|
|
2015-06-30 |
2015-06-30 |
B
Purchase
|
George Jean
Non-Executive Director
|
12,422
+15.9%
12.00
USD 149,064
|
12,422
+15.9%
|
12.00
|
USD 149,064
|
|
|
2015-06-30 |
2015-06-30 |
B
Purchase
|
George Jean
Non-Executive Director
|
91,166
+15.9%
12.00
USD 1,093,992
|
91,166
+15.9%
|
12.00
|
USD 1,093,992
|
|
|
2015-06-30 |
2015-06-30 |
B
Purchase
|
George Jean
Non-Executive Director
|
155,188
+15.9%
12.00
USD 1,862,256
|
155,188
+15.9%
|
12.00
|
USD 1,862,256
|
|
|
2015-06-30 |
2015-06-30 |
B
Purchase
|
GALAKATOS NICHOLAS
Non-Executive Director
Large shareholder
|
376,695
+15.9%
12.00
USD 4,520,340
|
376,695
+15.9%
|
12.00
|
USD 4,520,340
|
|
|
2015-06-30 |
2015-06-30 |
B
Purchase
|
Laufer Ron
Non-Executive Director
Large shareholder
|
223,439
+15.9%
12.00
USD 2,681,268
|
223,439
+15.9%
|
12.00
|
USD 2,681,268
|
|
|
2015-06-30 |
2015-06-30 |
B
Purchase
|
SVLSF V, LLC
Large shareholder
|
8,094
+15.9%
12.00
USD 97,128
|
8,094
+15.9%
|
12.00
|
USD 97,128
|
|
|
2015-06-30 |
2015-06-30 |
B
Purchase
|
SVLSF V, LLC
Large shareholder
|
382,996
+15.9%
12.00
USD 4,595,952
|
382,996
+15.9%
|
12.00
|
USD 4,595,952
|
|
|
2015-06-30 |
2015-06-30 |
B
Purchase
|
Clarus Lifesciences II, L.P.
Large shareholder
|
376,695
+15.9%
12.00
USD 4,520,340
|
376,695
+15.9%
|
12.00
|
USD 4,520,340
|
|
|
2015-06-30 |
2015-06-30 |
B
Purchase
|
MedImmune Ventures, Inc.
Large shareholder
|
223,439
+15.9%
12.00
USD 2,681,268
|
223,439
+15.9%
|
12.00
|
USD 2,681,268
|
|
